Miranda Hanson-Baseler

Miranda Hanson-Baseler

Dr. Miranda Hanson-Baseler is a Global Market Manager in Demand Generation. She joined QIAGEN in early 2015 as a technical and marketing writer for life sciences. Miranda received her Ph.D. in Immunology and Microbial Pathogenesis from West Virginia University in 2009. Prior to entering the biotech industry, she worked as a post-doctoral fellow in the Cancer and Inflammation Program at the National Cancer Institute, where she studied the immune mechanisms of a localized therapeutic for inflammatory bowel disease.



Antibiotic resistance

Combating drug-resistant superbugs

Antibiotics have been used for the last 80 years to treat patients with bacterial infections. While antibiotics have greatly reduced illness and death resulting from these infections, their use has been so prevalent that microbes have adapted to them, eliminating their effectiveness. These microbes are named antibiotic-resistant superbugs. Superbugs can acquire resistance genes either by… Read article →


SlideShare_Microbiomel_LabBench_700x300

Microbiome research tools on SlideShare

We have added our newest webinar presentations and posters covering the microbiome to SlideShare. Whether you want to learn how to isolate microbial DNA most efficiently or you’re wondering how qPCR can help you identify and profile microbial species, virulence genes and antibiotic resistance genes in your samples, we have a resource to help you… Read article →